hydrochlorothiazide has been researched along with 2-pyrazinoylguanidine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beyer, KH; Chambers, CE; Demers, LM; Passananti, GT; Vesell, ES | 1 |
| Beyer, KH; Gelarden, RT; Knutson, DW; Vary, JE; Vesell, ES; Ward, TD | 1 |
| A-Rahim, YI; Beyer, KH; Vesell, ES | 1 |
| Beyer, KH; Follansbee, MH; Griffith, JW; Vesell, ES | 1 |
1 trial(s) available for hydrochlorothiazide and 2-pyrazinoylguanidine
| Article | Year |
|---|---|
Effects of pyrazinoylguanidine on the glucose-fatty acid cycle in normal subjects and patients with non-insulin-dependent diabetes mellitus.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Down-Regulation; Fatty Acids; Female; Glucose Tolerance Test; Guanidines; Humans; Hydrochlorothiazide; Insulin; Male; Middle Aged; Pyrazines; Uremia | 1993 |
3 other study(ies) available for hydrochlorothiazide and 2-pyrazinoylguanidine
| Article | Year |
|---|---|
Contrasting effects of pyrazinoylguanidine and hydrochlorothiazide in patients with renal insufficiency.
Topics: Adult; Aged; Blood Glucose; Cholesterol; Electrolytes; Female; Guanidines; Humans; Hydrochlorothiazide; Male; Middle Aged; Pyrazines; Renal Insufficiency; Single-Blind Method; Triglycerides; Urea | 1993 |
Studies on pyrazinoylguanidine. 1. Characterization of metabolic effects in diabetic rats.
Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; Antihypertensive Agents; Blood Glucose; Cholesterol; Diabetes Mellitus, Experimental; Female; Guanidines; Hydrochlorothiazide; Hypoglycemic Agents; Hypolipidemic Agents; Lipids; Male; Pyrazines; Rats; Rats, Sprague-Dawley; Rats, Zucker; Streptozocin | 1996 |
Studies on pyrazinoylguanidine. 5. Temporal effects over 24 weeks demonstrating attenuation of diabetic nephropathy in STZ-diabetic rats.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Guanidines; Hydrochlorothiazide; Hypoglycemic Agents; Injections, Subcutaneous; Insulin; Kidney; Kidney Function Tests; Male; Molecular Weight; Pyrazines; Rats; Rats, Sprague-Dawley; Serum Albumin; Streptozocin | 1997 |